Such functionally compromised DCs trigger exhausted differentiation of CD8+ T cells in the TME, characterized by upregulated lymphocyte activation gene 3 and downregulated Ki67 40, ultimately impairing anti-tumor responses. This evidence concerns the gene CD8A and neoplasm.